Clinical research involving children

Introduction to the clinical research continuum

This section aims to address the different types of clinical trials in children along the full continuum of clinical research, from highly controlled early-phase confirmatory safety and efficacy trials to post-approval implementation science research in real-world settings. Understanding the paediatric-specific considerations at each phase is critical for selecting appropriate trial design and conducting the trials. 

The ultimate purpose of paediatric clinical research is to generate the evidence needed to ensure that children have timely access to safe, effective, appropriate, and feasible biomedical interventions. Fig. 2 illustrates the different phases and types of clinical research pre- and post-regulatory approval on a roadmap, demonstrating sequential steps towards successful approval, implementation and uptake of biomedical interventions for children. 

Fig. 2. A clinical trial roadmap towards successful implementation and better outcomes for children

 
A clinical trial roadmap towards successful implementation and better outcomes for children

The example in Fig. 2 presents clinical research as a sequential process, with classical drug development phases leading to regulatory approval and additional studies in the post-approval period to address knowledge gaps, such as long-term safety, effectiveness and utilization and influence changes in clinical guidelines and access policies. The results of clinical trials may not reflect actual use in real-world settings, where resources are limited and the patient population is more diverse. Implementation research methods, meant to illicit information on feasibility, acceptability and utilization, may be integrated into earlier phases of research instead of waiting until the post-approval period, to ultimately improve the success of trials in later phases and accelerate approval and the optimal use of medicines in the post-marketing period.

Integrating pragmatic approaches and data sources earlier in the paediatric clinical development pathway may result in the approval of safe and effective products that reach the children who need it most more quickly. Fig. 3 illustrates how different types of evidence, generated at different stages of clinical research can inform an optimal evidence package that leads to timely regulatory approval, recommendations for improved clinical use and optimal delivery of better medicines for children.

Clinical trials can therefore serve different yet complementary purposes: to support the approval of new products, to generate evidence that drives policy and guideline recommendations and to determine how interventions can be delivered most effectively in practice.

Fig. 3. Integrated approach to generating paediatric evidence for regulatory approval, policy change and optimal use

Fig. 3. Integrated approach to generating paediatric evidence for regulatory approval, policy change and optimal use

Subsequent sections describe the requirements and use of different trial types along this research continuum, organized by the clinical phases typically undertaken before regulatory approval and additional studies that are implemented in the post-approval phase.